Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Gene engineering preparation method of human pancreas secreted trypsin inhibitor

A trypsin inhibition and genetic engineering technology, applied in the field of human pancreatic secretory trypsin inhibitor, can solve the problems of high cost and few sources, and achieve the effect of low cost

Inactive Publication Date: 2006-07-26
SUN YAT SEN UNIV
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The present invention adopts genetic engineering technology to prepare recombinant human pancreatic secretory trypsin inhibitor to overcome the disadvantages of extraction from human tissue, high cost and few sources.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gene engineering preparation method of human pancreas secreted trypsin inhibitor
  • Gene engineering preparation method of human pancreas secreted trypsin inhibitor
  • Gene engineering preparation method of human pancreas secreted trypsin inhibitor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Example 1: Construction of recombinant expression plasmid pPIC9K-rHuPSTI

[0034] 1. Reagents and materials

[0035] The vector plasmids pPICZαA and pPIC9K were purchased from Invitrogen; the expression strain KM71 was purchased from Invitrogen; the recombinant human pancreatic secretory trypsin inhibitor gene was synthesized by Shanghai Boya Biotechnology Company; restriction enzymes and T4 DNA ligase were purchased from New England company, PCR primers were synthesized by Shanghai Boya Biotechnology Company, and the gel recovery kit was purchased from Omega Biotechnology Company.

[0036] 2. Method

[0037] (1) Synthesis of human pancreatic secretory trypsin inhibitor gene:

[0038] I. Primer synthesis: Due to the long nucleotide sequence of the gene, it is difficult to directly synthesize the target gene. Therefore, after technical and economical considerations, the full-length human gene was amplified by synthesizing four primers and PCR. Pancreatic Secretory Try...

Embodiment 2

[0056] Embodiment 2: Fermentation of Pichia pastoris engineered bacteria KM71 (pPIC9K-HuPSTI)

[0057] 1. Engineering bacteria: engineering bacteria KM71 (pPIC9K-HuPSTI);

[0058] 2. Medium:

[0059] YPD medium for primary seed bacteria activation (g / L): 20g peptone, 10g yeast powder, 20g glucose:

[0060] MGY medium for activation of secondary seed bacteria (g / L): ammonium sulfate 10g, YNB3.4g, glycerol 10g, biotin 4×10 -4 g;

[0061] Fermentation tank fermentation medium:

[0062] Basal medium: (NH4)2SO4 20g / L, glycerol 40g / L, KH2PO4 12g / L, CaSO4·2H2O 1g / L, Histidine 0.4g / L.

[0063] Trace element PTM1: CuSO4.5H2O 6.0g / L, NaI 0.08g / L, MgSO4·H2O 3.0g / L, ZnC12 20.0g / L, HBO4 0.02g / L, FeSO4·7H2O 65g / L, CoCl2 0.5g / L , Biotin 0.2g / L, NaMnO4 2H2O 0.2g / L, H2SO4 4ml / L.

[0064] Induced carbon source: 50% methanol + 25% glycerol (12ml PTM1 per liter)

[0065] 3. Activation of the seed bacterium: get the engineered strains (YPD plate) preserved in -70°C and 20% glycerol, cultiva...

Embodiment 3

[0070] Example 3: Preparation and purification of recombinant human pancreatic secretory trypsin inhibitor:

[0071] After using methanol to induce the secretory expression of human pancreatic secretory trypsin inhibitor for 96 hours, the supernatant was collected by centrifugation at 8000 rpm for 15 minutes at 4°C, and the supernatant was collected on Sepherdex G-25 molecular sieve (using 56mM Tris-HCl pH9.0 buffer Equilibrium in advance), collect the protein peak passing through the ultraviolet light, and sample the 15% SDS-PAGE electrophoresis detection result. The desalted and buffer-changed protein solution was loaded onto the Q Sepharose XL chromatography column (pre-equilibrated with 56mM Tris-HCl pH9.0 buffer), and after the UV was eluted to the baseline with the equilibration buffer, the protein peak passing through the UV was collected , sampling 15% SDS-PAGE electrophoresis detection results. Then use buffer 56mM Tris.HCl, 40mM KCl, pH 9.0 for one-step elution, col...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a process for preparing human pancreas secretion type trypsin Inhibitor through eucaryon secretory expression method comprising, (1) synthesizing human pancreas secretion type trypsin inhibitor genes possessing engineering bacterium codon preferring property and constructing expression vectors, (2) constructing and fermenting engineering bacterium, (3) preparing and purifying recombinant human pancreas secretion type trypsin Inhibitor preparations.

Description

technical field [0001] The invention belongs to the technical field of bioengineering, and relates to a genetic engineering production method of human pancreatic secretory trypsin inhibitor. Background technique [0002] Pancreatic Secretory Trypsin Inhibitor is a Kazal-type serine protease inhibitor present in the digestive system of mammals. Pancreatic secretory trypsin inhibitor is synthesized by pancreatic acinar cells and secreted into bile together with various amylases, lipases, proteolytic enzymes, etc. [0003] A large part of the proteolytic enzymes secreted by the pancreas are endogenous proteolytic enzymes, including trypsin, chymotrypsin, elastase and so on. These proteolytic enzymes can hydrolyze the peptide bonds between proteins and also cause damage to the pancreas itself. There are several ways in the body to ensure that proteolytic enzymes exist in an inactive state under certain circumstances to avoid autologous damage: exist in the duct of the pancreas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/55C12N15/57A61P1/18
Inventor 徐安龙任宇锋赖春娥区景行王磊
Owner SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products